QR Code

Exploring the naturally acquired response to Pvs47 gametocyte antigen

Malaria represents a challenging global public health task, with Plasmodium vivax being the predominant parasite in Brazil and the most widely distributed species throughout the world. Developing a vaccine against P. vivax malaria demands innovative strategies, and targeting gametocyte antigens show...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Gisele Tatiane Soares da Veiga, Rafael Amaral Donassolo, Sofia Forcellini, Julia Weber Ferraboli, Mario Antonio Kujbida Junior, Líndice Mitie Nisimura, Letícia Werzel Bassai, Rafael Luis Kessler, Mariana Serpeloni, Najara Carneiro Bittencourt, Yanka Evellyn Alves R. Salazar, Luiz Felipe Ferreira Guimarães, Jaime Louzada, Dayanne Kamylla Alves da Silva Barros, Stefanie Costa Pinto Lopes, Luzia Helena Carvalho, Tais Nóbrega de Sousa, Flora Satiko Kano, Fabio Trindade Maranhão Costa, Pryscilla Fanini Wowk, Letusa Albrecht
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2024-10-01
Rangatū:Frontiers in Immunology
Ngā marau:
antigenicity
Pvs47
gametocyte
transmission blocking vaccine
Plasmodium vivax
malaria
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1455454/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite